Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Asia-pacific Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2028

Published by Inkwood Research Product code 1018666
Published Content info 162 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia-pacific Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2028
Published: July 19, 2021 Content info: 162 Pages
Description

KEY FINDINGS

The Asia-Pacific sleep apnea therapeutics and diagnostics market is anticipated to register a CAGR of 8.35% during the forecast period, 2021-2028. The developing healthcare infrastructure and the rising healthcare expenditure are the dominant growth drivers.

MARKET INSIGHTS

South Korea, Australia & New Zealand, Japan, China, Vietnam, Indonesia, Thailand, India, and Rest of Asia-Pacific are evaluated for the Asia-Pacific sleep apnea therapeutics and diagnostics market growth analysis. In Japan, sleep apnea treatment devices include oral appliances, PAP devices, and adaptive servo ventilators. The usage of alternative therapies is considerably high in the country. According to an NCBI study, the usage of oral appliances was becoming common in patients aged 50 or above as of September 2019. Moreover, the country approved the usage of Inspire therapy, a neurostimulator, for treating sleep apnea.

In Australia & New Zealand, the prevalence of sleep apnea is estimated to be moderately high. The emerging sleep apnea therapeutics and diagnostics market is propelled by technological advancements in sleep apnea platforms and devices. However, the absence of a unified reimbursement policy hinders the market growth.

In South Korea, the expectant increase in the aged population drives market growth, apart from technological advancements. For instance, several local companies like NuEyne and Ybrain are developing wearable devices for sleep apnea treatment. The advancements also entail using piezoelectric sensors for pulse oximetry in sleep apnea patients. Such factors fuel the demand for sleep apnea devices.

COMPETITIVE INSIGHTS

Some of the key market players include: Vyaire Medical Inc, Koninklijke Philips NV, Nihon Kohden Corporation, BMC Medical Co Ltd, Teleflex Incorporated, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 24167

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGING AGING POPULATION AND OBESITY
    • 3.1.2. AWARENESS OF ILL EFFECTS OF UNTREATED SLEEP APNEA
    • 3.1.3. SLEEP APNEA INCIDENCES
    • 3.1.4. DEMAND FOR PORTABLE SLEEP APNEA DEVICES
    • 3.1.5. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGH COST OF SLEEP APNEA DEVICES
    • 3.2.2. LACK OF REIMBURSEMENTS
    • 3.2.3. DEARTH OF PATIENT COMPLIANCE

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. REGULATORY FRAMEWORK
  • 4.5. SUPPLY CHAIN ANALYSIS
  • 4.6. OPPORTUNITY MATRIX
  • 4.7. VENDOR LANDSCAPE

5. MARKET BY PRODUCT TYPE

  • 5.1. THERAPEUTICS
    • 5.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
    • 5.1.2. OXYGEN DEVICES
    • 5.1.3. MASKS AND ACCESSORIES
    • 5.1.4. ORAL APPLIANCES
    • 5.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES
  • 5.2. DIAGNOSTICS AND MONITORING
    • 5.2.1. POLYSOMNOGRAPHY DEVICE (PSG)
    • 5.2.2. OXIMETER
    • 5.2.3. ACTIGRAPHY MONITORING DEVICE
    • 5.2.4. RESPIRATORY POLYGRAPH
    • 5.2.5. SLEEP APNEA SCREENING DEVICE
    • 5.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES

6. MARKET BY END-USER

  • 6.1. HOSPITALS & SLEEP LABORATORIES
  • 6.2. HOME CARE SETTINGS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. ASIA-PACIFIC
    • 7.1.1. MARKET SIZE & ESTIMATES
    • 7.1.2. KEY GROWTH ENABLERS
    • 7.1.3. KEY CHALLENGES
    • 7.1.4. KEY PLAYERS
    • 7.1.5. COUNTRY ANALYSIS
      • 7.1.5.1. CHINA
      • 7.1.5.2. JAPAN
      • 7.1.5.3. AUSTRALIA & NEW ZEALAND
      • 7.1.5.4. INDIA
      • 7.1.5.5. SOUTH KOREA
      • 7.1.5.6. THAILAND
      • 7.1.5.7. INDONESIA
      • 7.1.5.8. VIETNAM
      • 7.1.5.9. REST OF ASIA-PACIFIC

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS & AGREEMENTS
    • 8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 8.2. COMPANY PROFILES
    • 8.2.1. BMC MEDICAL CO LTD
    • 8.2.2. BRAEBON MEDICAL CORPORATION
    • 8.2.3. CADWELL INDUSTRIES INC
    • 8.2.4. DEVILBISS HEALTHCARE LLC
    • 8.2.5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
    • 8.2.6. GE HEALTHCARE
    • 8.2.7. INVACARE CORPORATION
    • 8.2.8. ITAMAR MEDICAL LTD
    • 8.2.9. KONINKLIJKE PHILIPS NV
    • 8.2.10. MEDTRONIC PLC
    • 8.2.11. NIHON KOHDEN CORPORATION
    • 8.2.12. RESMED INC
    • 8.2.13. SMITHS MEDICAL INC
    • 8.2.14. SOMNOMEDICS GMBH
    • 8.2.15. TELEFLEX INCORPORATED
    • 8.2.16. VYAIRE MEDICAL INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS
  • TABLE 2: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: ASIA-PACIFIC THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: ASIA-PACIFIC THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: ASIA-PACIFIC DIAGNOSTICS AND MONITORING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: ASIA-PACIFIC DIAGNOSTICS AND MONITORING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: LEADING PLAYERS OPERATING IN ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • TABLE 13: LIST OF MERGERS & ACQUISITIONS
  • TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 16: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: ADVANTAGES OF PORTABLE CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES
  • FIGURE 2: KEY MARKET TRENDS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, IN 2020
  • FIGURE 7: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY THERAPEUTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS MARKET, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 9: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS MARKET, BY OXYGEN DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 10: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS MARKET, BY MASKS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
  • FIGURE 11: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS MARKET, BY ORAL APPLIANCES, 2021-2028 (IN $ MILLION)
  • FIGURE 12: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS MARKET, BY ADAPTIVE SERVO VENTILATION (ASV) DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 13: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY DIAGNOSTICS AND MONITORING, 2021-2028 (IN $ MILLION)
  • FIGURE 14: ASIA-PACIFIC DIAGNOSTICS AND MONITORING MARKET, BY POLYSOMNOGRAPHY DEVICE (PSG), 2021-2028 (IN $ MILLION)
  • FIGURE 15: ASIA-PACIFIC DIAGNOSTICS AND MONITORING MARKET, BY OXIMETER, 2021-2028 (IN $ MILLION)
  • FIGURE 16: ASIA-PACIFIC DIAGNOSTICS AND MONITORING MARKET, BY ACTIGRAPHY MONITORING DEVICE, 2021-2028 (IN $ MILLION)
  • FIGURE 17: ASIA-PACIFIC DIAGNOSTICS AND MONITORING MARKET, BY RESPIRATORY POLYGRAPH, 2021-2028 (IN $ MILLION)
  • FIGURE 18: ASIA-PACIFIC DIAGNOSTICS AND MONITORING MARKET, BY SLEEP APNEA SCREENING DEVICE, 2021-2028 (IN $ MILLION)
  • FIGURE 19: ASIA-PACIFIC DIAGNOSTICS AND MONITORING MARKET, BY OTHER DIAGNOSTICS AND MONITORING DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 20: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, IN 2020
  • FIGURE 21: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY HOSPITALS & SLEEP LABORATORIES, 2021-2028 (IN $ MILLION)
  • FIGURE 22: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY HOME CARE SETTINGS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 24: CHINA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 25: JAPAN SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 26: AUSTRALIA & NEW ZEALAND SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 27: INDIA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 28: SOUTH KOREA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: THAILAND SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: INDONESIA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: VIETNAM SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
Back to Top